1. Home
  2. CRTO vs EVO Comparison

CRTO vs EVO Comparison

Compare CRTO & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Criteo S.A.

CRTO

Criteo S.A.

HOLD

Current Price

$17.85

Market Cap

874.8M

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.72

Market Cap

994.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRTO
EVO
Founded
2005
1993
Country
France
Germany
Employees
3649
4553
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
874.8M
994.5M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
CRTO
EVO
Price
$17.85
$2.72
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
1
Target Price
$34.00
$7.00
AVG Volume (30 Days)
288.1K
28.7K
Earning Date
05-06-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
38.95
N/A
EPS
0.15
N/A
Revenue
$2,296,692,000.00
N/A
Revenue This Year
N/A
$1.37
Revenue Next Year
$5.54
$10.05
P/E Ratio
$116.07
N/A
Revenue Growth
27.65
N/A
52 Week Low
$15.58
$2.31
52 Week High
$26.40
$4.42

Technical Indicators

Market Signals
Indicator
CRTO
EVO
Relative Strength Index (RSI) 51.61 42.69
Support Level $16.98 $2.63
Resistance Level $19.81 $3.82
Average True Range (ATR) 0.75 0.07
MACD 0.03 -0.03
Stochastic Oscillator 43.16 27.55

Price Performance

Historical Comparison
CRTO
EVO

About CRTO Criteo S.A.

Criteo SA is an ad-tech company in the digital advertising market. Its technology allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. It has two reportable segments: Retail Media and Performance Media. Retail Media: This segment encompasses revenue generated from brands, agencies, and retailers for the purchase and sale of retail media digital advertising inventory and audiences, and services. Performance Media: This segment encompasses targeting capabilities and supply and AdTech services. The majority of its revenues is generated from the performance media segment.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: